Shares of Enzo Biochem, Inc. ENZ have lost 0.7% since the company reported its earnings for the quarter ended Jan. 31, 2025. This compares to the S&P 500 Index’s 0.6% gain over the same time frame.
Kingdom Capital Advisors, a private investment firm, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. Kingdom Capital Advisors is in its third year of ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results